|Year : 2018 | Volume
| Issue : 4 | Page : 148-152
A rolling ball like mass in right atrium of a 6 year old child
Srinivas Kola1, Tammiraju Iragavarapu2, Sushma Vutukuru3
1 Department of Ct surgery, Pinnamaneni Siddhartha Medical College, Gannavaram, Andhra pradesh, India
2 Department of Cardiology, Alluri Sita Ramaraju Academy of Medical College, Eluru, Andhra pradesh, India
3 Department of Pathology, Alluri Sita Ramaraju Academy of Medical College, Eluru, Andhra pradesh, India
|Date of Web Publication||17-Dec-2018|
Dr. Tammiraju Iragavarapu
Department of Cardiology, Asram Medical College, Eluru, Andhra Pradesh
Source of Support: None, Conflict of Interest: None
Cardiac myxoma is a common tumor occurring more commonly in the left atrium in adult females. Its occurrence in pediatric age group is rare; the more common tumors are rhabdomyoma and fibroma. Presentation of myxoma on the right side is still rarer in this age group. We report a case of a 6-year-old male child who presented with prolonged fever. On examination, there is an extra diastolic sound with mid-diastolic murmur. Echocardiogram is suggestive of a large ball-like polypoidal mass rolling in the right atrium traversing into the right ventricle. The case was immediately operated, and histopathology confirmed the tumor as myxoma. High index of suspicion is required to diagnose the condition to prevent disastrous complications as the presentation is often enigmatic because of vague constitutional findings in most of the cases.
Keywords: Child, myxoma, right atrium
|How to cite this article:|
Kola S, Iragavarapu T, Vutukuru S. A rolling ball like mass in right atrium of a 6 year old child. Heart India 2018;6:148-52
| Introduction|| |
Cardiac myxoma is a rare disease with an overall incidence of about 0.5/million/year and accounts for approximately 70% of all cardiac tumors occurring more commonly on the left side. By far, the most common type of tumors reported in children and adolescents is rhabdomyoma followed by fibroma, myxoma, and teratoma. We report a rare case report of myxoma of the right atrium occurring in a 6-year-old child.
| Case Report|| |
A 6-year-old boy presented with easy fatigability and low-grade fever for 6 months. He was initially evaluated by a pediatrician. The case was referred to our department in view of abnormal cardiac examination (extra heart sound which is varying with position). Other systems were normal. The chest X-ray showed clear lung fields with right atrial (RA) enlargement. An electrocardiogram showed sinus rhythm with right bundle branch block (RBBB). Two-dimensional echo, to our surprise, revealed a large mobile mass, 6 cm × 5 cm which is solitary, pedunculated with lobulated surface, and is intermittently blocking tricuspid valve. The case was immediately operated, and histopathology confirmed the tumor as myxoma.
| Discussion|| |
Cardiac tumors were first described in the 18th century by Boneti; however, many believe the description by Albers in 1835 is the first authentic report. Primary cardiac neoplasms are rare and occur with an estimated incidence of 0.0017%–0.19%, representing <5% of all heart tumors. Benign neoplasms occur 3 times more often than malignant tumors. Cardiac myxoma is a rare disease with an overall incidence of about 0.5/million/year and accounts for approximately 70% of all cardiac tumors. Incidence of cardiac tumors in pediatric age groups as described by Boston's children hospital are Rhabdomyomas-45%, Myxomas -23%, fibromas – 8%, others – 9%, nonspecified – 7%, and metastatic dissemination – 7%. The age of those patients diagnosed with metastatic tumor involvement ranged from 6 to 15 years of age.
Cardiac myxoma is a globular or polypoid mass that usually arises from the region of the fossa ovalis and is attached to the underlying endocardium by a pedicle. The etiology of cardiac myxomas is not fully understood, but they are thought to originate in undifferentiated and totipotent mesenchymal stem cells that are capable of neural and endothelial differentiation., Myxomas produce vascular endothelial growth factor, which probably contributes to the induction of angiogenesis and the early stages of tumor growth., Mutations of the protein kinase A regulatory subunit gene PRKAR1A cause inherited myxomas in the setting of the Carney complex tumor syndrome, providing a possible window for understanding their pathogenesis. Recent investigations have revealed that interleukin-6 in plasma is the cause of constitutional manifestations.
Approximately 70% of affected patients are women predominantly between the third and sixth decades of life, with a mean age of 53.9 (19–79) years. They are rarely seen in children, accounting for only 9%–15% of all cardiac tumors from birth to adolescence, and the usual site of location is left atrium. Right-sided tumors are uncommon, and myxomas are the most common tumors of the right atrium. However, sarcomas and, in particular, angiosarcomas have been reported to arise in the right atrium. The RA myxoma originates in the fossa ovalis or base of the interatrial septum; our patient is very young (6 years) which is a rare presentation.
The clinical presentation of a patient with a cardiac tumor is determined more by the tumor's location than by its histologic type. RA myxomas may remain asymptomatic. Approximately 7% of all cardiac myxomas occur in association with Carney's complex. Carney's complex, as described by J. A. Carney, is characterized by the association of cutaneous pigmentation, fibromyxoid tumors of the skin, myxomas of the heart, endocrine overactivity, and autosomal dominant inheritance. Cardiac tumors may cause symptoms through a variety of mechanisms. Myxomas present with a classic triad of symptoms, including cardiac obstruction (80%), emboli (70%), and systemic illness (65%). These patients can have an increased risk for acute cardiogenic shock or sudden cardiac death. Typical cardiovascular signs and symptoms are those of right heart failure (i.e. fatigue, peripheral edema, hepatomegaly, ascites, and prominent “a waves” in the jugular veins) in case of RA myxoma. On physical examination, a diastolic murmur has been described, which is similar to the “tumor plop” heard with left atrial myxomas.
In addition to obstructing circulation through the right side of the heart, tumor fragments may be released into the pulmonary circulation, causing symptoms consistent with pulmonary emboli. RA hypertension can result in shunting of venous blood into the systemic circulation if a patent foramen ovale (or atrial septal defect) is present, resulting in hypoxemia or systemic emboli.,
Electrocardiography may show specific chamber enlargements, features of pulmonary artery hypertension, and RBBB if any due to tumor. Echocardiography remains the best diagnostic method for locating and assessing the extent of myxomas and for detecting their recurrence, with a sensitivity of up to 100%. In our case, two-dimensional (2D) echo confirmed RA myxomas originating near fossa ovalis traversing the tricuspid valve [Figure 1]. However, transthoracic echocardiogram may not identify tumors smaller than 5 mm in diameter, and a transesophageal echocardiogram (TEE) is required when there is suspicion of a very small tumor. The superior diagnostic utility of TEE is due to the proximity of the esophagus to the heart, the lack of intervening lung and bone, and the ability to use high-frequency imaging transducers that afford superior spatial resolution. Magnetic resonance imaging is a powerful tool in diagnosing tumors, evaluating their extent, and seeking metastases. It may delineate the area of the mass better than echocardiography because it has a larger field of observation. Contrast enhancement and multislice imaging can provide a 3D view of tissue. It also can help differentiate tumors from thrombi.
|Figure 1: (a) Two-dimensional echo four-chamber view showing large ball-like polypoidal mass traversing the tricuspid valve with calcifications (arrow). (b) Modified short-axis view showing large mass measuring 6 cm × 4 cm|
Click here to view
Treatment and prognosis
Once a presumptive diagnosis of myxoma has been made on imaging studies, prompt resection is required because of the risk of embolization or cardiovascular complications, including sudden death.,, Surgical excision of cardiac myxomas is the mode of treatment and carries a low operative risk and gives excellent short- and long-term results. The operative mortality ranges from 0% to 3% in multiple series. The survival after surgery is elevated. Right-sided cardiac myxomas present surgeons with a technical challenge because placement of the cannula for cardiopulmonary bypass can be difficult. Tumor fragmentation, followed by embolization of myxomatous debris, can be a serious intraoperative complication of this procedure. The risk of this can be greatly reduced, though, by manipulating the heart as little as possible during cannulation and tumor excision. Resection should be complete, including all of pedicle and area attachments, plus a margin safety.
Grossly typical myxomas are pedunculated and gelatinous in consistency; the surface may be smooth, villous, or friable [Figure 2]. Tumors vary widely in size. Histologically, these tumors are composed of scattered cells termed lipidic cells within a mucopolysaccharide stroma [Figure 3]. These cells are multinucleated with pink cytoplasm. Typically, they present in clusters surrounding vascular structures. Calcium is present in approximately 10% of patients with a higher incidence of calcification in right-sided tumors. Usually, the embolized material has a different pattern from the material at the center of the lesion.
|Figure 2: (a) Intraoperative image of excision of the right atrial myxoma. (b) Excised right atrial myxoma, postoperative image|
Click here to view
|Figure 3: Histopathologic section studied shows lobules of mature adipose tissue with clear vacuolated cytoplasm and eccentrically placed nucleus with intervening thin fibrous septa and scant blood vessels. Background shows myxoid areas suggestive of myxoma|
Click here to view
The recurrence rate of sporadic tumors is very low between 1% and 3% and may occur within a few months to several years after the initial surgical excision and most are found during the first 4 years. Incomplete resection, intraoperative displacement, embolization, and multifocal genesis have been proposed as possible explanations. Cardiac autotransplantation (with atrial reconstruction) or transplantation are potential options for the treatment of recurrent atrial myxoma.,
Features of cardiac myxoma are mentioned in [Table 1] with special emphasis on right-sided myxomas.
| Conclusion|| |
RA myxoma is rare and its presentation in a 6-year-old child is still rarer. Their presentation is often enigmatic because of vague constitutional findings. Early consideration, expeditious diagnosis, and prompt surgical intervention can avoid profound illness and death in these patients.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Azevedo O, Almeida J, Nolasco T, Medeiros R, Casanova J, Bartosch C, et al.
Massive right atrial myxoma presenting as syncope and exertional dyspnea: Case report. Cardiovasc Ultrasound 2010;8:23.
Reynen K. Cardiac myxomas. N Engl J Med 1995;333:1610-7.
Cho BK, Lee DY, Pezzella AT, Hong SN, Hong PW. Surgical treatment of atrial myxomas: A report of 20 cases. Tex Heart Inst J 1989;16:81-5.
Pucci A, Gagliardotto P, Zanini C, Pansini S, di Summa M, Mollo F, et al.
Histopathologic and clinical characterization of cardiac myxoma: Review of 53 cases from a single institution. Am Heart J 2000;140:134-8.
Kono T, Koide N, Hama Y, Kitahara H, Nakano H, Suzuki J, et al.
Expression of vascular endothelial growth factor and angiogenesis in cardiac myxoma: A study of fifteen patients. J Thorac Cardiovasc Surg 2000;119:101-7.
Sakamoto H, Sakamaki T, Kanda T, Tsuchiya Y, Sato M, Sato H, et al.
Vascular endothelial growth factor is an autocrine growth factor for cardiac myxoma cells. Circ J 2004;68:488-93.
Yin Z, Kirschner LS. The carney complex gene PRKAR1A plays an essential role in cardiac development and myxomagenesis. Trends Cardiovasc Med 2009;19:44-9.
Kamiya H, Yasuda T, Nagamine H, Sakakibara N, Nishida S, Kawasuji M, et al.
Surgical treatment of primary cardiac tumors: 28 years' experience in Kanazawa University Hospital. Jpn Circ J 2001;65:315-9.
Manfroi W, Vieira SR, Saadi EK, Saadi J, Alboim C. Multiple recurrences of cardiac myxomas with acute tumoral pulmonary embolism. Arq Bras Cardiol 2001;77:161-6.
Ojji DB, Ajiduku SS, Omonua OO, Abdulkareem LL, Parsonage W. A probable right atrial myxoma prolapsing through the tricuspid valve into the right ventricle: A case report. Cases J 2008;1:386.
Diaz A, Di Salvo C, Lawrence D, Hayward M. Left atrial and right ventricular myxoma: An uncommon presentation of a rare tumour. Interact Cardiovasc Thorac Surg 2011;12:622-3.
Stolf NA, Benício A, Moreira LF, Rossi E. Right atrium myxomaoriginatingfrom the inferior vena cava: An unusual location with therapeutic anddiagnostic implications. Rev Bras Cir Cardiovasc 2000;15:255-8.
Yuce M, Dagdelen S, Ergelen M, Eren N, Caglar N. A huge obstructive myxoma located in the right heart without causing any symptom. Int J Cardiol 2007;114:405-6.
Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation and endocrine overactivity. Medicine (Baltimore) 1985;64:270-83.
Sheu CC, Lin SF, Chiu CC, Lee CS, Chai CY, Liu YC, et al.
Left atrial sarcoma mimicking obstructive pulmonary disease. J Clin Oncol 2007;25:1277-9.
Vassiliadis N, Vassiliadis K, Karkavelas G. Sudden death due to cardiac myxoma. Med Sci Law 1997;37:76-8.
Kuon E, Kreplin M, Weiss W, Dahm JB. The challenge presented by right atrial myxoma. Herz 2004;29:702-9.
Savino JS, Weiss SJ. Images in clinical medicine. Right atrial tumor. N Engl J Med 1995;333:1608.
Diaz Castro O, Bueno H, Nebreda LA. Acute myocardial infarction caused by paradoxical tumorous embolism as a manifestation of hepatocarcinoma. Heart 2004;90:e29.
Chen MY, Wang JH, Chao SF, Hsu YH, Wu DC, Lai CP, et al.
Cardiac myxoma originating from the anterior mitral leaflet. Jpn Heart J 2003;44:429-34.
Engberding R, Daniel WG, Erbel R, Kasper W, Lestuzzi C, Curtius JM, et al.
Diagnosis of heart tumours by transoesophageal echocardiography: A multicentre study in 154 patients. European Cooperative Study Group. Eur Heart J 1993;14:1223-8.
Beroukhim RS, Prakash A, Buechel ER, Cava JR, Dorfman AL, Festa P, et al.
Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging: A multicenter experience. J Am Coll Cardiol 2011;58:1044-54.
Keeling IM, Oberwalder P, Anelli-Monti M, Schuchlenz H, Demel U, Tilz GP, et al.
Cardiac myxomas: 24 years of experience in 49 patients. Eur J Cardiothorac Surg 2002;22:971-7.
Selkane C, Amahzoune B, Chavanis N, Raisky O, Robin J, Ninet J, et al.
Changing management of cardiac myxoma based on a series of 40 cases with long-term follow-up. Ann Thorac Surg 2003;76:1935-8.
Cina SJ, Smialek JE, Burke AP, Virmani R, Hutchins GM. Primary cardiac tumors causing sudden death: A review of the literature. Am J Forensic Med Pathol 1996;17:271-81.
Guhathakurta S, Riordan JP. Surgical treatment of right atrial myxoma. Tex Heart Inst J 2000;27:61-3.
Talley JD, Wenger NK. Atrial myxoma: Overview, recognition, and management. Compr Ther 1987;13:12-8.
Oliveira R, Branco L, Galrinho A, Abreu A, Abreu J, Fiarresga A, et al.
Cardiac myxoma: A 13-year experience in echocardiographic diagnosis. Rev Port Cardiol 2010;29:1087-100.
Gammie JS, Abrishamchian AR, Griffith BP. Cardiac autotransplantation and radical bi-atrial resection for recurrent atrial myxoma. Ann Thorac Surg 2007;83:1545-7.
Goldstein DJ, Oz MC, Michler RE. Radical excisional therapy and total cardiac transplantation for recurrent atrial myxoma. Ann Thorac Surg 1995;60:1105-7.
[Figure 1], [Figure 2], [Figure 3]